Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WDC vs MRNA✓SelectedUSD · MRNAWDC vs MRNA performance historyLatest closeAs of+1.72%11/18
Stock and ETF performance explorer

WDC vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+709.2%
MRNA return
+156.2%
Excess return
+552.9%
Maximum drawdown
-64.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.7%-4.8%+6.6%+1.9%
7D-8.0%-20.9%+12.9%-7.2%
30D-18.2%-13.3%-4.9%-17.7%
3M-41.9%+212.6%-254.5%-45.4%
6M-37.1%+309.0%-346.2%-45.1%
YTD+67.5%+567.3%-499.8%+31.8%
1Y+88.9%+689.7%-600.8%+44.0%
All+709.2%+156.2%+552.9%+583.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling